FDA Approves Visian Toric ICL for astigmatism. What it means.

September 20, 2018 by Sam Ven4


On September 13, 2018, STAAR Surgical announced the approval by the FDA of the Visian Toric ICL (TICL) for the correction of myopia with astigmatism. Before the announcement, the Visian ICL (implantable collamer lens) product line in the United States only consisted of lenses that offer correction for patients with myopia (nearsightedness). Visian ICL patients with astigmatism would require an additional LASIK procedure to correct that refractive error. Price Vision Group has been performing procedures with the standard Visian ICL since 2004.
This announcement is incredible news for our patients with high myopia and astigmatism who were not candidates for LASIK or PRK. “FDA’s approval of STAAR’s Visian Toric ICL in the U.S. provides an exciting treatment option for myopic patients with astigmatism in search of visual freedom. We are thrilled to be able to offer this lens in the United States and look forward to officially making the Visian Toric ICL available to U.S. surgeons for their patients on November 1st, 2018,” said Caren Mason, President & CEO.
Offering our patients the best vision correction options is our top priority and we will update our patients on the availability of the Visian Toric ICL when we receive them.
To learn more about the Visian ICL and to see if it’s right for you, please click here.
*Update*
The Visian Toric ICL is now available and we’re proud to be the first clinic in Indiana to implant the ICL.
 


4 comments

  • Uma Kota

    November 27, 2018 at 2:26 pm

    When will the astigmatism lenses be made available in US now that FDA has approved it?

    Reply

    • Sam Ven

      November 27, 2018 at 2:30 pm

      Thanks for your question. The Visian Toric ICLs are now available. We implanted the first lens on November 8.

      Reply

  • Cos Velasquez

    December 11, 2018 at 8:48 pm

    What is the total cost of the service and what does that include?

    Reply

  • Steve Koufos

    May 6, 2021 at 6:25 pm

    For perspective, will you share with us what percentage of your refractive business is ICLs or TICLs? Are you seeing growth?

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *


Price Vision Group logo horiz white

Price Vision Group is a global leader in corneal transplant, cataract surgery, keratoconus treatment, PRK and LASIK. At our center in Indianapolis, we see patients from Indiana cities including Zionsville, Fishers, Carmel, Noblesville, Avon, and Greenwood, as well as people who travel from across the U.S. and even abroad for treatment by our renowned physicians.

Copyright 2022 Price Vision Group. All rights reserved.